$ECIA

ENCISION INC

CIK:0000930775|SEC Filings

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
NET REVENUE:
Total revenue	$ 1,528,050	$ 1,755,388	$ 3,130,778	$ 3,386,318
COST OF REVENUE:
Total cost of revenue	830,717	926,906	1,554,986	1,615,173
GROSS PROFIT	697,333	828,482	1,575,792	1,771,145
OPERATING EXPENSES:
Sales and marketing	395,793	458,480	800,394	881,716
General and administrative	358,639	373,405	686,838	725,310
Research and development	201,392	155,515	366,832	294,695
Total operating expenses	955,824	987,400	1,854,064	1,901,721
OPERATING (LOSS)	(258,491)	(158,918)	(278,272)	(130,576)
Interest expense, net	(11,384)	(10,598)	(29,393)	(16,967)
Other (expense) income, net	2,042	(746)	(1,301)	(679)
Interest expense and other income (expense), net	(9,342)	(11,344)	(30,694)	(17,646)
(LOSS) BEFORE PROVISION FOR INCOME TAXES	(267,833)	(170,262)	(308,966)	(148,222)
Provision for income taxes	0	0	0	0
NET (LOSS)	$ (267,833)	$ (170,262)	$ (308,966)	$ (148,222)
Net (loss) per share - basic	$ (0.02)	$ (0.01)	$ (0.02)	$ (0.01)
Net (loss) per share - diluted	$ (0.02)	$ (0.01)	$ (0.02)	$ (0.01)
Weighted average shares - basic	14,187,337	11,875,145	13,033,491	11,875,145
Weighted average shares - diluted	14,187,337	11,875,145	13,033,491	11,875,145
Product [Member]
NET REVENUE:
Total revenue	$ 1,481,802	$ 1,653,820	$ 2,974,634	$ 3,245,779
COST OF REVENUE:
Total cost of revenue	805,734	882,886	1,472,545	1,550,520
GROSS PROFIT	676,068	770,934	1,502,089	1,695,259
Service [Member]
NET REVENUE:
Total revenue	46,248	101,568	156,144	140,539
COST OF REVENUE:
Total cost of revenue	24,983	44,020	82,441	64,653
GROSS PROFIT	$ 21,265	$ 57,548	$ 73,703	$ 75,886

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows (used in) operating activities:
Net (loss)	$ (308,966)	$ (148,222)
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization	48,570	42,525
Stock-based compensation expense related to stock options	22,651	25,011
Provision for potential inventory obsolescence	2,569	83,152
Change in operating assets and liabilities:
Right of use asset, net	56,656	(6,909)
Accounts receivable	24,524	74,127
Inventories	11,750	154,520
Prepaid expenses and other assets	(55,968)	15,935
Accounts payable	(49,487)	(26,678)
Accrued compensation and other accrued liabilities	5,552	(20,762)
Net cash (used in) provided by operating activities	(242,149)	192,699
Cash flows (used in) investing activities:
Acquisition of property and equipment	(43,215)	(42,559)
Patent and Trademark costs	(11,933)	(17,359)
Net cash (used in) investing activities	(55,148)	(59,918)
Cash flows from financing activities:
(Repayments) Borrowing from line of credit	(364,258)	(77,834)
(Payments) from options exercised	0	(1,449)
Proceeds from issuance of common stock	500,000	0
(Paydown) Draw on Secured notes	(24,147)	134,007
Net cash provided by financing activities	111,595	54,724
Net (decrease) increase in cash	(185,702)	187,505
Cash, beginning of fiscal year	257,433	42,509
Cash, end of six months	71,731	230,014
Supplemental disclosures of cash flow information:
Cash paid during the year for interest	$ 29,393	$ 16,967

Condensed Balance Sheets - USD ($)	Sep. 30, 2025	Mar. 31, 2025
Current assets:
Cash	$ 71,731	$ 257,433
Accounts receivable	761,947	786,471
Inventories	1,468,863	1,483,182
Prepaid expenses	144,331	85,679
Total current assets	2,446,872	2,612,765
Equipment:
Furniture, fixtures and equipment, at cost	2,628,661	2,585,446
Accumulated depreciation	(2,378,645)	(2,340,689)
Equipment, net	250,016	244,757
Right of use asset	1,116,454	568,395
Patents, net	161,427	171,890
Other assets	81,990	72,892
TOTAL ASSETS	4,056,759	3,670,699
Current liabilities:
Accounts payable	314,815	346,900
Line of credit	31,706	395,964
Secured notes	35,202	44,128
Accrued compensation	199,657	180,850
Deferred Revenue	0	17,401
Other accrued liabilities	147,019	160,274
Accrued lease liability	343,172	430,398
Total current liabilities	1,071,571	1,575,915
Long-term liabilities:
Secured notes	162,249	177,470
Accrued lease liability	958,152	266,212
Total liabilities	2,191,972	2,019,597
Commitments and contingencies (Note 4)
Shareholders’ equity:
Preferred stock, no par value: 10,000,000 shares authorized; none issued and outstanding	0	0
Common stock and additional paid-in capital, no par value: 100,000,000 shares authorized; 16,879,645 and 11,879,645 issued and outstanding at September 30, 2025, and March 31, 2025, respectively	24,938,998	24,416,347
Accumulated (deficit)	(23,074,211)	(22,765,245)
Total shareholders’ equity	1,864,787	1,651,102
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 4,056,759	$ 3,670,699